Back to results
US 12,594,288 B2Granted
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
AssigneeAbbott Laboratories
InventorsRachael Buck, Debra Thomas, Joseph Schaller
Life of this patent
Estimating the term…
Abstract
Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
Claims20
A shelf stable synthetic pediatric formula, in the form of a liquid or reconstitutable powder, for reducing inflammation comprising
- from about 40 mg/L to about 350 mg/L of at least one of cytidine 5′-monophosphate, uridine 5′-monophosphate, adenosine 5′-monophosphate, guanosine 5′-monophosphate, and combinations thereof;
- from about 0.01 mg/mL to about 10 mg/ml of at least one of 3′-sialylactose and 6′-sialylactose;
- at least one of docosahexaenoic acid and arachidonic acid;
- and
- wherein the synthetic pediatric formula is shelf stable for at least three months.
2 more elements
A method for reducing inflammation due to a viral infection in an infant, toddler, or child in need thereof, the method comprising administering to the infant, toddler, or child a nutritional composition comprising
- from about 40 mg/L to about 350 mg/L of at least one of cytidine 5′-monophosphate, uridine 5′-monophosphate, adenosine 5′-monophosphate, guanosine 5′-monophosphate, and combinations thereof;
- from about 0.01 mg/mL to about 10 mg/ml of at least one of 3′-sialylactose and 6′-sialylactose;
- wherein the nutritional composition is shelf stable for at least three months.
Dependencies are inferred from the claim text.